15:30-17:10 |
Scientific Session 9: Basic Science: Big Data research |
16:00-16:10 |
55: OP32: Mincle signaling promotes intestinal mucosal inflammation through induction of macrophage pyroptosis and neutrophil chemotaxis in Crohn's Disease |
08:30-10:20 |
Scientific Session 10: Multidisciplinary cases |
18:00-18:06 |
DOP15: Transmural healing with vedolizumab in patients with active Crohn's Diesease |
18:06-18:12 |
DOP16: An evaluation of the exposure-efficacy relationship for subcutaneous vedolizumab maintenance treatment of Chron's Diesease: Pharmacokinetic findings from VISIBLE 2 |
17:30-17:36 |
DOP19: Real-world healthcare resource utilisation among patients with Inflammatory Bowel Disease administered vedolizumab for 6 months |
17:54-18:00 |
DOP23: Endoscopic evaluation at one month after Ileocolic resection for Crohn's Disease predicts postoperative recurrence and is safe |
17:43-17:49 |
DOP49: Quantitative proteomics analysis of macrophages from Crohn's Disease patients and infected with adherent-invasive Escherichia coli |
17:37-17:43 |
DOP66: A CEACAM5 small peptide restores the suppressive activity of CD8 + T cells in patients with Crohn's Disease |
17:49-17:55 |
DOP68: Thiomyristoyl Ameliorates Colitis by blocking the differentiation of Th17 Cells via STAT3/IL-6 Signal Pathway |
18:13-18:19 |
DOP90: The role of Nlrp9b, a novel NLR member in regulating experimental colitis |
6th Y-ECCO Basic Science Workshop
15:30-15:45 |
Whole blood TREM-1, marker of anti-TNF non-responsiveness in IBD |
14th N-ECCO Network Meeting
11:45-12:00 |
N01:Factors related to self-medication with corticosteroids, aminosalicylates or analgesics and reasons given by patients with Ulcerative Colitis from Spain Sabela Fernandez, Madrid, Spain |